Mesa Labs Inc (MLAB)

$139.61 +2.45 (1.79%)
Market Cap 744.97M
Revenue (ttm) 216.19M
Net Income (ttm) -254.25M
EPS (ttm) N/A
PE Ratio 16.78
Forward PE 17.73
Profit Margin -117.60%
Debt to Equity Ratio 1.27
Volume 30,000
Avg Vol 39,552
Day's Range N/A - N/A
Shares Out 5.43M
Stochastic %K 43%
Beta 0.82
Analysts Sell
Price Target $133.33

Latest News on MLAB

MESA LABS DECLARES QUARTERLY DIVIDEND

Jan 6, 2025, 3:00 PM EST - 11 days ago

MESA LABS DECLARES QUARTERLY DIVIDEND

Mesa Labs Announces Second Quarter Results

Nov 7, 2024, 8:00 AM EST - 2 months ago

Mesa Labs Announces Second Quarter Results

Mesa Labs Announces First Quarter Results

Aug 5, 2024, 8:00 AM EDT - 5 months ago

Mesa Labs Announces First Quarter Results

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results

Jun 5, 2024, 6:00 AM EDT - 8 months ago

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results

May 31, 2024, 6:00 AM EDT - 8 months ago

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024

May 22, 2024, 6:00 AM EDT - 8 months ago

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024

MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES

Apr 8, 2024, 8:00 AM EDT - 10 months ago

MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES

Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024

Apr 1, 2024, 10:27 AM EDT - 10 months ago

Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024

Mesa Labs Releases Second Annual Responsible Business Program Brochure

Mar 15, 2024, 7:00 AM EDT - 11 months ago

Mesa Labs Releases Second Annual Responsible Business Program Brochure

Mesa Labs Announces Third Quarter Results

Feb 5, 2024, 8:00 AM EST - 1 year ago

Mesa Labs Announces Third Quarter Results

Mesa Laboratories Appoints Mark Capone to its Board of Directors

Jan 8, 2024, 8:00 AM EST - 1 year ago

Mesa Laboratories Appoints Mark Capone to its Board of Directors

Mesa Labs Completes the Acquisition of GKE Science & Technology Co.

Jan 3, 2024, 8:00 AM EST - 1 year ago

Mesa Labs Completes the Acquisition of GKE Science & Technology Co.

Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024

Dec 14, 2023, 10:47 AM EST - 1 year ago

Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024

Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform

Oct 16, 2023, 3:00 AM EDT - 1 year ago

Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023

Sep 13, 2023, 1:37 PM EDT - 1 year ago

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023

Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions

Aug 24, 2023, 4:02 PM EDT - 1 year ago

Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions

Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023

Jun 21, 2023, 11:50 AM EDT - 1 year ago

Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023

Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results

May 25, 2023, 8:00 AM EDT - 1 year ago

Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results

Mesa Laboratories: Divisional Growth, Valuations Supportive Of Hold

Feb 27, 2023, 8:26 PM EST - 2 years ago

Mesa Laboratories: Divisional Growth, Valuations Supportive Of Hold

Mesa Labs Declares Quarterly Dividend

Jan 3, 2023, 5:00 PM EST - 2 years ago

Mesa Labs Declares Quarterly Dividend

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023

Dec 16, 2022, 11:59 AM EST - 2 years ago

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023

Mesa Labs Acquires Belyntic's Peptide Purification Business

Nov 17, 2022, 8:04 AM EST - 2 years ago

Mesa Labs Acquires Belyntic's Peptide Purification Business

Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

Nov 4, 2022, 3:49 PM EDT - 2 years ago

Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

Jun 27, 2022, 8:01 AM EDT - 2 years ago

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

May 31, 2022, 8:00 AM EDT - 2 years ago

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

Mesa Labs Closes Acquisition of Agena Bioscience

Oct 20, 2021, 12:05 PM EDT - 3 years ago

Mesa Labs Closes Acquisition of Agena Bioscience

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

Sep 14, 2021, 7:00 AM EDT - 3 years ago

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

Mesa Laboratories: Q4 Earnings Insights

Jun 1, 2021, 9:56 AM EDT - 3 years ago

Mesa Laboratories: Q4 Earnings Insights

Mesa Labs Reports Third Quarter Results for FY21

Feb 3, 2021, 8:00 AM EST - 4 years ago

Mesa Labs Reports Third Quarter Results for FY21

Mesa Labs Reports Second Quarter Results for FY21

Nov 5, 2020, 8:00 AM EST - 4 years ago

Mesa Labs Reports Second Quarter Results for FY21

Mesa Labs Reports First Quarter Results

Aug 6, 2020, 8:00 AM EDT - 4 years ago

Mesa Labs Reports First Quarter Results

Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering

Jun 16, 2020, 11:52 AM EDT - 4 years ago

Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering

Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock

Jun 9, 2020, 8:15 PM EDT - 5 years ago

Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock

Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock

Jun 8, 2020, 4:01 PM EDT - 5 years ago

Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock

Recap: Mesa Laboratories Q4 Earnings

Jun 1, 2020, 8:07 AM EDT - 5 years ago

Recap: Mesa Laboratories Q4 Earnings

Life Sciences Executive Shannon Hall Joins Mesa Labs Board of Directors

May 15, 2020, 8:00 AM EDT - 5 years ago

Life Sciences Executive Shannon Hall Joins Mesa Labs Board of Directors

MESA LABS DECLARES QUARTERLY DIVIDEND

Jan 9, 2020, 7:00 PM EST - 5 years ago

MESA LABS DECLARES QUARTERLY DIVIDEND

Mesa Labs Acquires Gyros Protein Technologies

Oct 31, 2019, 8:55 PM EDT - 5 years ago

Mesa Labs Acquires Gyros Protein Technologies

Mesa Laboratories, Inc: The Big Mover That Most Investors Aren't Aware Of

Jun 3, 2019, 8:21 AM EDT - 6 years ago

Mesa Laboratories, Inc: The Big Mover That Most Investors Aren't Aware Of